Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Checking for abdominal aortic aneurysm in people with lung cancer

Scans check the abdominal aorta for aneurysms in adults with primary lung cancer.

Plain-language title generated from the registry record
Registry title: Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Key facts

Where
Kunming, ChinaSee the 2 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with primary lung cancer who agree to imaging of the abdominal aorta. It studies how often abdominal aortic aneurysm occurs together with lung cancer.

Age
20 Years to 90 Years
Sex
All sexes can join.
Disease stage
Primary lung cancer, diagnosed by clinical or pathological examination. No stage is given.

Main reasons for not taking part

  • Refuses imaging screening of the abdominal aorta

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 90 years old?

Source: NCT06775821, who can take part

Where in China

  • The First Affiliated Hospital of Kunming Medical UniversityKunming, ChinaContact: Yun-fei shi, MphilTaking people
  • The Third Affiliated Hospital of Kunming Medical UniversityKunming, ChinaContact: Xu-dong Xiang, MPhilTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
First Affiliated Hospital of Kunming Medical University
Trial code
NCT06775821
Record updated
15 January 2025
Original description
Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.Read full original descriptionShow less

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.

Inclusion: Patients diagnosed with primary lung cancer through clinical or pathological examination.

Exclusion: Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.

ClinicalTrials.gov NCT06775821